Abstract
The follicular non-Hodgkin’s lymphomas are B-cell neoplasms which typically present in an advanced stage, often with bone marrow involvement and diffuse adenopathy. Patients are usually middle aged and asymptomatic at presentation. Many give a history of adenopathy coming and going for several years preceding the pathologic diagnosis. There are three histologic subtypes of follicular lymphoma: follicular small cleaved cell (FSC), follicular mixed small cleaved and large cell (FM), and follicular large cell (FLC) (nodular poorly differentiated lymphocytic, nodular mixed poorly differentiated, and histiocytic or nodular histiocytic, respectively, in the Rappaport classification). Of these, FSC is the most common, comprising about 23% of all non-Hodgkin’s lymphomas. Some studies suggest that there are important differences in the natural course of the disease and response to treatment between the three subtypes while others have failed to confirm these. It is important to recognize that there is great variability in the pathologic criteria and reproducibility in the subclassification of the follicular lymphomas, even among expert pathologists. Futhermore, multiple (discordant) histologic subtypes are found in as many as 20%–30% of patients when more than one biopsy is obtained at diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rosenberg SA (1985) Karnofsky Memorial Lecture: the low grade non-Hodgkin’s lymphomas: challenges and opportunities J Clin Oncol 3: 299
Jones SE (1986) Follicular lymphoma do no harm. Cancer Treat Rep 70: 1055
Horning SJ, Rosenberg SA (1984) The natural history of initially untreated low grade non-Hodgkin’s lymphomas. N Engl J Med 311: 1471
Anderson KC, Skarin AT, Rosenthal DJ, Maclntyre JM, Pinkus GS, Case DC Jr, Leonard RC, Canellos GP (1984) Combination chemotherapy for advanced non-Hodgkin’s lymphomas other than diffuse histiocytic or undifferentiated histologies. Cancer Treat Rep 68: 1343
Foon KA, Sherwin SA, Abrams PG, Longo DL, Fer MF, Stevenson HC, Ochs JJ, Bottino GC, Schoenberger CS, Zeffren J, Jaffe ES, Oldham RK (1984) Treatment of advanced non-Hodgkin’s lymphoma with recombinant leukocyte -interferon. N Engl J Med 311: 1148
Horning SJ (1984) Interferon and malignant lyn, ma. In: Zoon KC, Noguchi PD, Liu T-Y (eds) Interferon: Research, clinical application and regulatory consideration. Elsevier, New York, p 229
Miller RA, Maloney DG, Warnke R, Levy R (1982) Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med 306: 517
Meeker T, Lowder J, Cleary ML, Stewart S, Warnke R, Sklar J, Levy R (1985) Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. N Engl J Med 312: 1658
Cleary ML, Chao J, Warnke R, Sklar J (1984) Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc N- I Acad Sci USA 81: 593
Cheson BD, Wittes RE, Friedman MA (1986) Low-grade non-Hodgkin’s lymphomas revisited. Cancer Treat Rep 70: 1051
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Horning, S.J. (1989). Follicular Non-Hodgkin’s Lymphomas. In: Magrath, I. (eds) New Directions in Cancer Treatment. UICC International Union Against Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83405-9_48
Download citation
DOI: https://doi.org/10.1007/978-3-642-83405-9_48
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19063-9
Online ISBN: 978-3-642-83405-9
eBook Packages: Springer Book Archive